Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
$12.63
+0.2850 ( +2.31% ) 705.2K
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
Market Data
Open
$12.63
Previous close
$12.34
Volume
705.2K
Market cap
$849.42M
Day range
$11.94 - $12.80
52 week range
$2.05 - $19.05
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 75 | May 15, 2024 |
4 | Insider transactions | 1 | Apr 24, 2024 |
def | Proxies and info statements | 5 | Apr 18, 2024 |
8-k | 8K-related | 12 | Apr 16, 2024 |
pre | Proxies and info statements | 5 | Apr 08, 2024 |
8-k | 8K-related | 12 | Apr 08, 2024 |
8-k | 8K-related | 15 | Apr 03, 2024 |
10-k | Annual reports | 124 | Mar 28, 2024 |
8-k | 8K-related | 16 | Mar 28, 2024 |
8-k | 8K-related | 14 | Mar 25, 2024 |